Clinical and Experimental Nephrology

, Volume 17, Issue 4, pp 504–514 | Cite as

Dephosphorylated Ser985 of c-Met is associated with acquired resistance to rechallenge injury in rats that had recovered from uranyl acetate-induced subclinical renal damage

  • Tomoyuki Fujikura
  • Akashi Togawa
  • Yuan Sun
  • Takamasa Iwakura
  • Hideo Yasuda
  • Yoshihide Fujigaki
Original Article



We previously reported that rats that had recovered from mild proximal tubule (PT) injury induced by a sub-toxic dose of uranyl acetate (UA) showed partial resistance to a subsequent nephrotoxic dose of UA in association with reduced renal dysfunction and accelerated PT proliferation. We demonstrated that this resistance may involve hepatocyte growth factor (HGF)/c-Met signaling. Here, we examined whether primary cultured tubular cells derived from this model had acquired sensitivity to HGF.


Tubular cells were isolated by collagenase digestion from rat kidneys after recovery from UA-induced mild PT injury and were cultured for 48 h. Their survival and proliferation were examined using the MTS assay/5-bromo-2′-deoxyuridine labeling or MTS assay, respectively, and their migration was assayed using wound-healing and cell scattering assays, with/without HGF. HGF/c-Met signaling was assayed using phospho-specific antibodies.


HGF-stimulated cultured tubular cells from UA-treated rats showed better survival after UA exposure and higher proliferation and migration than cells from vehicle-treated rats. Furthermore, HGF induced higher phosphorylation of c-Met (Tyr1234/1235) and of its major downstream signals (AKT and extracellular signal-regulated kinase 1/2) with maintained dephosphorylation of Ser985 as a negative regulator of HGF/c-Met signaling in the tubular cells of UA-treated rats compared to those of vehicle-treated rats. Immunohistochemically, dephosphorylated Ser985 was confirmed in PT cells in vivo.


These results suggest that elevated sensitivity to HGF, via dephosphorylated Ser985 of c-Met of tubular cells that had recovered from mild tubular injury, may be associated with cytoprotection, accelerated proliferation and migration.


Acquired resistance Hepatocyte growth factor c-Met Uranyl acetate Proximal tubule cell 


  1. 1.
    Jo SK, Rosner MH, Okusa MD. Pharmacologic treatment of acute kidney injury: why drugs haven’t worked and what is on the horizon. Clin J Am Soc Nephrol. 2007;2:356–65.PubMedCrossRefGoogle Scholar
  2. 2.
    Honda N, Hishida A, Ikuma K, Yonemura K. Acquired resistance to acute renal failure. Kidney Int. 1987;31:1233–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Furuya R, Kumagai H, Hishida A. Acquired resistance to rechallenge injury with uranyl acetate in LLC-PK1 cells. J Lab Clin Med. 1997;129:347–55.PubMedCrossRefGoogle Scholar
  4. 4.
    Zager RA, Burkhart KM, Johnson AC, Sacks BM. Increased proximal tubular cholesterol content: implications for cell injury and “acquired cytoresistance”. Kidney Int. 1999;56:1788–97.PubMedCrossRefGoogle Scholar
  5. 5.
    Zager RA. Plasma membrane cholesterol: a critical determinant of cellular energetics and tubular resistance to attack. Kidney Int. 2000;58:193–205.PubMedCrossRefGoogle Scholar
  6. 6.
    Kawaida K, Matsumoto K, Shimazu H, Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994;91:4357–61.PubMedCrossRefGoogle Scholar
  7. 7.
    Wang Z, Chen JK, Wang SW, Moeckel G, Harris RC. Importance of functional EGF receptors in recovery from acute nephrotoxic injury. J Am Soc Nephrol. 2003;14:3147–54.PubMedCrossRefGoogle Scholar
  8. 8.
    Villegas G, Lange-Sperandio B, Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int. 2005;67:449–57.PubMedCrossRefGoogle Scholar
  9. 9.
    Sharples EJ. Acute kidney injury: stimulation of repair. Curr Opin Crit Care. 2007;13:652–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Sun Y, Fujigaki Y, Sakakima M, Hishida A. Acquired resistance to rechallenge injury in rats recovered from subclinical renal damage with uranyl acetate—importance of proliferative activity of tubular cells. Toxicol Appl Pharmacol. 2010;243:104–10.PubMedCrossRefGoogle Scholar
  11. 11.
    Sun Y, Fujigaki Y, Sakakima M, Fujikura T, Togawa A, Huang Y, et al. Acquired resistance to rechallenge injury in rats that recovered from mild renal damage induced by uranyl acetate: accelerated proliferation and hepatocyte growth factor/c-Met axis. Clin Exp Nephrol. 2011;15:666–75.PubMedCrossRefGoogle Scholar
  12. 12.
    Fujigaki Y, Goto T, Sakakima M, Fukasawa H, Miyaji T, Yamamoto T, et al. Kinetics and characterization of initially regenerating proximal tubules in S3 segment in response to various degrees of acute tubular injury. Nephrol Dial Transplant. 2006;21:41–50.PubMedCrossRefGoogle Scholar
  13. 13.
    Fujigaki Y, Sakakima M, Sun Y, Fujikura T, Tsuji T, Yasuda H, et al. Cell division and phenotypic regression of proximal tubular cells in response to uranyl acetate insult in rats. Nephrol Dial Transplant. 2009;24:2686–92.PubMedCrossRefGoogle Scholar
  14. 14.
    Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int. 2001;59:2023–38.PubMedGoogle Scholar
  15. 15.
    Rampino T, Gregorini M, Dal Canton A. Scatter factors in renal disease: Dr. Jekyll and Mr. Hyde? Cytokine Growth Factor Rev. 2009;20:77–85.PubMedCrossRefGoogle Scholar
  16. 16.
    Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol. 2010;11:834–48.PubMedCrossRefGoogle Scholar
  17. 17.
    Dai C, Yang J, Liu Y. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol. 2002;13:411–22.PubMedGoogle Scholar
  18. 18.
    Fiaschi-Taesch NM, Santos S, Reddy V, Van Why SK, Philbrick WF, Ortega A, et al. Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: the efficacy of parathyroid hormone-related protein and hepatocyte growth factor. J Am Soc Nephrol. 2004;15:112–25.PubMedCrossRefGoogle Scholar
  19. 19.
    Vijayan A, Martin DR, Sadow JL, Kissane J, Miller SB. Hepatocyte growth factor inhibits apoptosis after ischemic renal injury in rats. Am J Kidney Dis. 2001;38:274–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Maeshima A, Sakurai H, Nigam SK. Adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into developing kidney. J Am Soc Nephrol. 2006;17:188–98.PubMedCrossRefGoogle Scholar
  21. 21.
    Li M, Zhang Y, Bharadwaj U, Zhai QJ, Ahern CH, Fisher WE, et al. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res. 2009;15:5993–6001.PubMedCrossRefGoogle Scholar
  22. 22.
    Shin K, Wang Q, Margolis B. PATJ regulates directional migration of mammalian epithelial cells. EMBO Rep. 2007;8:158–64.PubMedCrossRefGoogle Scholar
  23. 23.
    de Rooij J, Kerstens A, Danuser G, Schwartz MA, Waterman-Storer CM. Integrin-dependent actomyosin contraction regulates epithelial cell scattering. J Cell Biol. 2005;171:153–64.PubMedCrossRefGoogle Scholar
  24. 24.
    Togawa A, Sfakianos J, Ishibe S, Suzuki S, Fujigaki Y, Kitagawa M, et al. Hepatocyte growth factor stimulated cell scattering requires ERK and Cdc42-dependent tight junction disassembly. Biochem Biophys Res Commun. 2010;400:271–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Prozialeck WC, Lamar PC, Lynch SM. Cadmium alters the localization of N-cadherin, E-cadherin, and beta-catenin in the proximal tubule epithelium. Toxicol Appl Pharmacol. 2003;189:180–95.PubMedCrossRefGoogle Scholar
  26. 26.
    Prozialeck WC, Lamar PC, Appelt DM. Differential expression of E-cadherin, N-cadherin and beta-catenin in proximal and distal segments of the rat nephron. BMC Physiol. 2004;4:10.PubMedCrossRefGoogle Scholar
  27. 27.
    Gandino L, Longati P, Medico E, Prat M, Comoglio PM. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. J Biol Chem. 1994;269:1815–20.PubMedGoogle Scholar
  28. 28.
    Hashigasako A, Machide M, Nakamura T, Matsumoto K, Nakamura T. Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J Biol Chem. 2004;279:26445–52.PubMedCrossRefGoogle Scholar
  29. 29.
    Rabkin R, Fervenza F, Tsao T, Sibley R, Friedlaender M, Hsu F, et al. Hepatocyte growth factor receptor in acute tubular necrosis. J Am Soc Nephrol. 2001;12:531–40.PubMedGoogle Scholar
  30. 30.
    Liu Y, Sun AM, Dworkin LD. Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem Biophys Res Commun. 1998;246:821–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Hara-Chikuma M, Verkman AS. Aquaporin-1 facilitates epithelial cell migration in kidney proximal tubule. J Am Soc Nephrol. 2006;17:39–45.PubMedCrossRefGoogle Scholar
  32. 32.
    Nony PA, Schnellmann RG. Mechanisms of renal cell repair and regeneration after acute renal failure. J Pharmacol Exp Ther. 2003;304:905–12.PubMedCrossRefGoogle Scholar
  33. 33.
    Liu Y, Tolbert EM, Lin L, Thursby MA, Sun AM, Nakamura T, et al. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int. 1999;55:442–53.PubMedCrossRefGoogle Scholar
  34. 34.
    Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci. 2010;86:588–610.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2012

Authors and Affiliations

  • Tomoyuki Fujikura
    • 1
  • Akashi Togawa
    • 2
  • Yuan Sun
    • 1
  • Takamasa Iwakura
    • 1
  • Hideo Yasuda
    • 1
  • Yoshihide Fujigaki
    • 1
  1. 1.Internal Medicine 1Hamamatsu University School of MedicineHamamatsuJapan
  2. 2.Shizuoka Saiseikai General HospitalShizuokaJapan

Personalised recommendations